In Bacterial infections Neopred Tablet is an antibiotic which works by stopping the growth of infection causing bacteria on your skin. It prevents the synthesis of essential proteins necessary for survival of bacteria. It is effective against skin infections such as boils, impetigo and infected hair follicles. It may also be used to treat infections in small cuts or wounds on your skin. This treatment has few common side effects and should clear up infections within a few days, but you should keep using it for as long as it is prescribed. In Hepatic encephalopathy Hepatic encephalopathy is a severe liver disease that can cause changes in brain function leading to confusion, tremors (shaking), sleep problems and loss of consciousness. Neopred Tablet lowers the levels of ammonia-producing bacteria in the blood which has harmful effects on the brain. If taken as prescribed, this medicine can improve your brain function and reduce the symptoms associated with hepatic encephalopathy.
It is not known whether it is safe to consume alcohol with Neopred Tablet. Please consult your doctor.
Neopred Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Neopred Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Neopred Tablet does not usually affect your ability to drive.
Neopred Tablet should be used with caution in patients with kidney disease. Dose adjustment of Neopred Tablet may be needed. Please consult your doctor.
There is limited information available on the use of Neopred Tablet in patients with liver disease. Please consult your doctor.
If you miss a dose of Neopred Tablet, please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Leeford Healthcare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Universal Twin Labs || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Micro Labs Ltd || ₹14.5/tablet (25% cheaper)